Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Zymfentra (Infliximab-dyyb) REal World Cohort STudy

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT07237516
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:12.780528+00:00
Published At
2026-03-17T00:00:00+00:00
Record Updated At
2026-03-17
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Ulcerative Colitis (UC)", "Crohn\u0027s Disease (CD)", "Indeterminate Colitis", "Inflammatory Bowel Disease (IBD)"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-03-17"
protocolSection.identificationModule.nctId
"NCT07237516"
protocolSection.identificationModule.officialTitle
"Zymfentra (Infliximab-dyyb) REal World Cohort STudy"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Ulcerative Colitis (UC) (protocolSection.conditionsModule.conditions)
  • Crohn's Disease (CD) (protocolSection.conditionsModule.conditions)
  • Indeterminate Colitis (protocolSection.conditionsModule.conditions)
  • Inflammatory Bowel Disease (IBD) (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.